Home About us Articles Multimedia Search Instructions Login 
IF 2017: 1.596 (® Clarivate Analytics)
Total Cites: 7606
Q2 in Medicine, General & Internal
Follow Us
Follow Us
  • Users Online: 679
  • Home
  • Print this page
  • Email this page
Year : 2018  |  Volume : 131  |  Issue : 8  |  Page : 966-973

Relationships between Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Diseases: Clinical Assessments, Biomarkers, and Treatment

Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China

Correspondence Address:
Dr. Shu-Qin Zhan
Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0366-6999.229886

Rights and Permissions

Objective: Rapid eye movement sleep behavior disorder (RBD) is characterized by dream enactment and loss of muscle atonia during rapid eye movement sleep. RBD is closely related to α-synucleinopathies including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Many studies have investigated the markers of imaging and neurophysiological, genetic, cognitive, autonomic function of RBD and their predictive value for neurodegenerative diseases. This report reviewed the progress of these studies and discussed their limitations and future research directions. Data Sources: Using the combined keywords: “RBD”, “neurodegenerative disease”, “Parkinson disease”, and “magnetic resonance imaging”, the PubMed/MEDLINE literature search was conducted up to January 1, 2018. Study Selection: A total of 150 published articles were initially identified citations. Of the 150 articles, 92 articles were selected after further detailed review. This study referred to all the important English literature in full. Results: Single-nucleotide polymorphisms in SCARB2 (rs6812193) and MAPT (rs12185268) were significantly associated with RBD. The olfactory loss, autonomic dysfunction, marked electroencephalogram slowing during both wakefulness and rapid eye movement sleep, and cognitive impairments were potential predictive markers for RBD conversion to neurodegenerative diseases. Traditional structural imaging studies reported relatively inconsistent results, whereas reduced functional connectivity between the left putamen and substantia nigra and dopamine transporter uptake demonstrated by functional imaging techniques were relatively consistent findings. Conclusions: More longitudinal studies should be conducted to evaluate the predictive value of biomarkers of RBD. Moreover, because the glucose and dopamine metabolisms are not specific for assessing cognitive cognition, the molecular metabolism directly related to cognition should be investigated. There is a need for more treatment trials to determine the effectiveness of interventions of RBD on preventing the conversion to neurodegenerative diseases.


 Abstract in Chinese



数据来源:使用“RBD”、“神经退行性疾病”、“帕金森病”和“磁共振成像”结合的关键词,PubMed / MEDLINE文献检索到2018年1月1日。
结果:SCARB2(rs6812193)和MAPT(rs12185268)的单核苷酸多态性与RBD显著相关。 清醒和快速眼动睡眠期间EEG减慢、嗅觉丧失、自主神经功能障碍、认知障碍是RBD转化为神经退行性疾病的潜在预测标记。传统的结构影像学研究结果相对不一致,而功能成像技术显示的左侧壳核和黑质的功能连接、多巴胺转运蛋白摄取的降低是相对一致的结果。
结论:应进行更多的纵向研究来评估生物标记物对RBD转化为神经退行性疾病的预测价值。 此外,葡萄糖和多巴胺代谢的结果对于评估认知功能并不特异,因此应探讨与认知功能直接相关的代谢分子在RBD发病中的参与作用。另外需要更多的临床试验来确定RBD干预措施对于预防神经退行性疾病的有效性。

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded258    
    Comments [Add]    

Recommend this journal